Ocugen (OCGN) is grabbing investors’ attention with its stock climbing 195% in the past year and its modifier gene therapy platform, which promises to deliver one-time treatments that could change the ...

The latest announcement is out from Ocugen ( (OCGN) ).

The future may be looking up for Ocugen (OCGN) stock after the biotech company announced a change in leadership. Ramesh Ramachandran will take over as the company’s new principal financial officer and ...

Ocugen Inc (NASDAQ:OCGN) shares are trading higher during Monday’s session after the company received clearance from the U.S. FDA for its Investigational New Drug amendment to start a Phase 2/3 ...

Ocugen (NASDAQ:OCGN) stock fans will want to keep an eye on the clinical-stage biopharmaceutical company as it has big news coming on Wednesday. That’s when Ocugen plans to hold a clinical showcase ...

Ocugen Inc (NASDAQ:OCGN) shares are trading higher by 25.6% to $2.06 during Monday’s session. The stock is trading higher, potentially on upward momentum, after the Third Circuit Court of Appeals last ...

Ocugen (OCGN) is climbing 5% after investment bank H.C. Wainwright raised its price target on the shares to $8 from $7. OCGN, whose stock is currently trading around 69 cents, develops gene therapies ...